Zhejiang Taimei Medical Technology Co., Ltd. (FRA:A2V)

Germany · Delayed Price · Currency is EUR

0.5800

-0.0050 (-0.85%)

Last updated: Aug 26, 2026, 3:25 PM CET

4.50% (1Y)

Market Cap	337.33M +9.7%
Revenue (ttm)	62.41M -7.0%
Net Income	-5.22M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.5600
Previous Close	0.5850
Day's Range	0.5600 - 0.5800
52-Week Range	0.3780 - 0.8100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About FRA:A2V

Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, eCooperate, eArchives, eImage medical imaging evaluation system, eSMS si... [Read more]

Industry Commercial Physical and Biological Research

Founded 2013

Country China

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol A2V

Financial Performance

In 2025, FRA:A2V's revenue was 512.54 million, a decrease of -7.01% compared to the previous year's 551.16 million. Losses were -42.85 million, -80.04% less than in 2024.

Financial numbers in CNY Financial Statements